Differences

This shows you the differences between two versions of the page.

--- content:mycophenolate_mofetil [2022/04/30 11:32] – changed pubmed syntax administrator@icnapedia.org
+++ content:mycophenolate_mofetil [2022/04/30 11:54] (current) – changed pubmed syntax administrator@icnapedia.org
@@ Line 1: / Line 1: @@
 ====== Mycophenolate Mofetil ======
-Mycophenolate Mofetil is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. MMF is promising in immune-mediated neuromuscular disorders. MMF has been used for the treatment of polymyositis, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy. MMF can be effective alone but mainly as an adjuvant therapy by reducing steroid requirements or the frequency of infusions of IVIg. MMF has also been tested alone as a single drug treatment or in combination with immunomodulatory drugs in multiple sclerosis in open surveillance trials or in phase II studies [(:cite:pmid15803931>{{pmid>short:15803931}})].
+Mycophenolate Mofetil is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. MMF is promising in immune-mediated neuromuscular disorders. MMF has been used for the treatment of polymyositis, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy. MMF can be effective alone but mainly as an adjuvant therapy by reducing steroid requirements or the frequency of infusions of IVIg. MMF has also been tested alone as a single drug treatment or in combination with immunomodulatory drugs in multiple sclerosis in open surveillance trials or in phase II studies [(:cite:pmid15803931>{{pmid>long:15803931}})].
 **Mechanism of action**